KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Maxlinear (MXL) EBT (2016 - 2025)

Historic EBT for Maxlinear (MXL) over the last 17 years, with Q4 2025 value amounting to -$17.8 million.

  • Maxlinear's EBT rose 5638.87% to -$17.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$140.9 million, marking a year-over-year increase of 4097.86%. This contributed to the annual value of -$140.9 million for FY2025, which is 4097.86% up from last year.
  • Maxlinear's EBT amounted to -$17.8 million in Q4 2025, which was up 5638.87% from -$43.4 million recorded in Q3 2025.
  • Over the past 5 years, Maxlinear's EBT peaked at $45.0 million during Q1 2022, and registered a low of -$82.5 million during Q3 2024.
  • Its 5-year average for EBT is -$11.1 million, with a median of -$12.5 million in 2021.
  • Per our database at Business Quant, Maxlinear's EBT soared by 70312.05% in 2022 and then tumbled by 76819.33% in 2024.
  • Quarter analysis of 5 years shows Maxlinear's EBT stood at $28.5 million in 2021, then soared by 42.96% to $40.7 million in 2022, then plummeted by 204.71% to -$42.6 million in 2023, then rose by 4.24% to -$40.8 million in 2024, then surged by 56.39% to -$17.8 million in 2025.
  • Its EBT stands at -$17.8 million for Q4 2025, versus -$43.4 million for Q3 2025 and -$30.7 million for Q2 2025.